Background This study determined the prevalence of glucagon-like peptide-1 (GLP-1) use before total joint arthroplasty (TJA), measured weight loss of patients on GLP-1s, and evaluated if GLP-1s were associated with outcomes. Methods We identified 6482 patients (2990 hips; 3492 knees) who had primary TJAs between 2019 a...
Michael W. Seward, Emmett J. Cleary, Anthony C. DeNovio et al.· Arthroplasty Today· 0 citations
Technology-assisted THA was associated with modest increases in index and 90-day episode-of-care costs compared with manual techniques, and further evaluation of cost-effectiveness and broader clinical benefits is warranted as the use of enabling technologies expands.
Jaques L. Williams, Adrián E. González-Bravo, James P. Moriarty et al.· Journal of Arthroplasty· 0 citations
Revision THA carries a low 30- and 90-day mortality risk that is not associated with the extent of revision, but is strongly impacted by the indication for revision, which faces a 3- and 4-fold higher risk of mortality within 90 days compared to aseptic loosening.
D. J. Restrepo, Adrián E. González-Bravo, S. G. Guarin Perez et al.· Journal of Arthroplasty· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.